Although no statistically significant differences were observed, an increasing trend in the Firmicutes/Bacteroidota ratio was evident in both the obesity and MASLD groups ( Fig. 1F ).
← all excerpts
Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease.
1
—
—